Skip to main content Skip to main navigation
Government logo | to homepage of National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Nederlands
  • English
  • Home
  • News

News


Search

Fill in your search phrase.

Topics

  • (-) Flu and flu vaccine (2)
  • (-) WHO Collaborating Centre for Tobacco Product Regulation and Control (2)
  • International (6)
  • COVID-19 (2)
  • COVID-19 vaccination (2)
  • Tobacco (2)
  • HPV vaccination (1)
  • Immunisation and vaccination (1)
  • Nanotechnology (1)
  • Perinatal screening (1)

Publication date

  • September 2021 (1)
  • September 2016 (2)
  • April 2014 (1)

Flu jab for additional groups

The flu jab is offered free of charge every year to people aged 60 years and older, and to people who are at higher risk of becoming seriously ill from the flu virus due to medical reasons
09/22/2021 - 11:00

Moderate flu season

Last winter season, the duration and severity of the influenza epidemic was moderate compared to previous years.

09/29/2016 - 00:00

Assessment of health effects of alternative tobacco products

To assess the effects on the health of users of alternative tobacco products, more knowledge is required about the composition of the product, the smoker’s behaviour (such as the amount of cigarett

09/08/2016 - 00:00

RIVM investigates dangers of e-cigarette

At the request of State Secretary Martin van Rijn (VWS), RIVM is carrying out an investigation into the safety of e-cigarettes.

04/16/2014 - 00:00

Share this page


  • Facebook
  • Twitter
  • LinkedIn
  • WhatsApp
  • Email

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Copyright
  • Responsible disclosure
  • Website archive

Languages

  • English
  • Nederlands

Volg ons

  • RIVM Newsletters
  • RSS reed
  • Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram